Schmallenberg virus: could infection of wildlife species result in an ever-present threat to livestock? by Tarlinton, Rachael E. et al.
1 
 
Schmallenberg virus: could infection of wildlife species result in an ever-present 1 
threat to livestock? 2 
R. Tarlinton, J Daly, S. Dunham, J.H. Kydd 3 
School of Veterinary Medicine and Science, University of Nottingham, Sutton 4 
Bonington, Loughborough, Leicestershire, LE12 5RD, United Kingdom 5 
 6 
Schmallenberg virus (SBV) is the most recent vector-borne disease to pose a 7 
threat to Europe’s livestock industry. Since its recognition in northern Germany 8 
in April 2011, the range of SBV has continued to expand, infecting thousands of 9 
domestic ruminants in many European countries.  10 
Initial reports of the clinical impact of SBV infection were restricted to cattle, 11 
sheep and occasionally goats. However, because the vectors (Culicoides spp.) 12 
ingest blood meals from a wide variety of animal hosts, researchers have started 13 
to monitor for the presence of this virus in related wildlife species. The paper by 14 
Larska and others in this issue reports the detection of SBV RNA in the serum of 15 
a Polish elk calf that died of bronchopneumonia (though it is unclear whether 16 
there was a causal relationship). They also report detection of SBV antibodies in 17 
the only remaining free-living herd of European Bison, raising the possibility that 18 
SBV could be a direct threat to endangered ruminant species. Finally, they 19 
additionally report the detection of antibodies in wild (and farmed) red deer. 20 
Although antibodies were undetectable in fallow deer, samples from these 21 
animals were all taken prior to the detection of antibodies in red deer and bison. 22 
This data adds to reports documenting SBV seropositive samples in a variety of 23 
species of wild ruminants in Europe including fallow, red, roe and Sika deer, 24 
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chamois and reindeer (Barlow et al., 2013; Linden et al., 2012; Schiefer et al., 25 
2013). The observations by Larska and others raise important questions about 26 
the risk of establishment of an endemic transmission cycle of SBV in wildlife 27 
species in Europe. The relative risk posed by wildlife populations is likely to be 28 
determined by multiple factors including population density and proximity to 29 
livestock, presence of insect vectors, and local climatic conditions. 30 
Although several wildlife species seroconvert to SBV, indicating exposure, there 31 
is as yet no evidence that they suffer overt clinical disease. Therefore, a key 32 
question is whether these animals develop sufficiently high levels of viraemia to 33 
transmit virus onwards via feeding Culicoides. Detection of viral RNA has only 34 
been reported for one wildlife species, the elk calf documented by Larska and 35 
others. There have been no reports of fetal malformations in wild ruminants but, 36 
as several of the citations have indicated, aborted fetuses in wild populations are 37 
unlikely to be found due to scavenging by carnivores, and fewer animals of these 38 
species are farmed.  39 
Akabane virus (AKAV), a close relative of SBV, is endemic in northern Australia. 40 
A peculiarity of AKAV in this region is it can re-emerge in the face of over 90% 41 
seropositivity in adult cattle (Kirkland, 2002). SBV may already be exhibiting 42 
similar epidemiology in Europe, with re-circulation of virus in Belgium in 2012 43 
(Bayrou et al., 2013; Claine et al., 2013) despite seroprevalence of 84% and 44 
86% in the national herds of sheep and cattle, respectively, in 2011 (Meroc et 45 
al., 2013a; Meroc et al., 2013b). Cryptic transmission in a wildlife reservoir could 46 
contribute to the continued circulation of virus. No wildlife reservoir species for 47 
AKAV in Australia have been identified. However, a serosurvey study of 48 
Akabane-like (Simbu group) viruses in Kenya identified positive samples in 14 49 
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different species of domestic and wild ruminants and equidae (Davies and 50 
Jessett, 1985).  51 
It is also informative to consider the role of wild ruminants in the epidemiology 52 
of bluetongue virus (BTV), which is also transmitted by Culicoides midges. BTV 53 
can infect a variety of wild ruminants (reviewed in (Falconi et al., 2011)). 54 
Usually, infection is subclinical in species indigenous to regions where BTV is 55 
endemic, such as South Africa, where wild ruminants are regarded as reservoir 56 
hosts. Mandatory vaccination of livestock is thought to have played a major role 57 
in bringing the epidemic of BTV that affected cattle and sheep herds in northern 58 
Europe in 2006/7 under control (Zientara et al., 2010). The subsequent decline 59 
of seroprevalence in Belgian red deer (Linden et al., 2010) suggests that wild 60 
ruminants are not able to indefinitely sustain BTV circulation in Europe, although 61 
the potential exists (Falconi et al., 2011).  62 
The availability of an SBV vaccine places us in a better position to control the 63 
disease now than when it first emerged, albeit at a cost to farmers with already 64 
tight financial margins. However, it appears from anecdotal evidence that many 65 
farmers in the UK are choosing not to vaccinate against SBV, partly due to the 66 
assumption that the virus will “burn itself out” as BTV apparently has previously. 67 
Is this justified optimism or just wishful thinking? 68 
Wild and feral deer populations cover a large proportion of Europe and 69 
population sizes have increased dramatically over recent years. The paper by 70 
Larska and others adds further weight to the need to study SBV in wild 71 
ruminants in order to understand the risk they pose in maintaining circulation of 72 
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